Chemiluminescent Nitrogen Detection (CLND) to Measure Kinetic Aqueous Solubility

Abstract

Solubility is the dose‐limiting property for in vitro studies, and therefore is a critical physicochemical property to measure in drug discovery. Solubility data can be used to guide lead optimization, troubleshoot erratic bioassay results, and identify potential downstream liabilities such as insufficient solubility for bioassays or oral bioavailability. Typically, early in vitro studies are performed using library compounds prepared as dimethylsulfoxide (DMSO) stock solutions, resulting in in vitro test solutions containing DMSO at low concentration (<5% v/v). Since DMSO can affect the apparent solubility, it is desirable to obtain solubility data under conditions mimicking the in vitro study. Kinetic solubility (from DMSO stock solutions) is often preferred over thermodynamic solubility (from dry powder) in early drug discovery. The protocols in this article describe a general procedure for assessing kinetic aqueous solubility of early drug discovery compounds using a miniaturized shake flask method with chemiluminescent nitrogen detection (CLND). Curr. Protoc. Chem. Biol. 5:269‐280 © 2013 by John Wiley & Sons, Inc.

Extended pharmacodynamic responses observed upon PROTAC-mediated degradation of RIPK2

“…Nevertheless, the microsomal turnover of 2 in both rat and human microsomes was found to be very high (11 and 29 mL/min/g liver in rat and human microsomes, respectively), suggesting that this compound would have limited utility as an in vivo tool molecule. Additionally, this compound was found to have poor solubility as determined via a high-throughput precipitation assay using chemiluminescent nitrogen-specific detection (CLND) 22,23 . We hypothesised that reducing the lipophilicity of 2 would have a beneficial impact on reducing microsomal turnover and would also increase its solubility.…”

Searching for New Leads for Tuberculosis: Design, Synthesis, and Biological Evaluation of Novel 2-Quinolin-4-yloxyacetamides

“…23 Regarding the methyl group at position 2, its replacement with a trifluoromethyl or a propyl group led to inactive compounds (19 and 24). For all the compounds (19)(20)(21)(22)(23)(24) possessing a trifluoromethyl group in position 2, the extremely poor solubility and higher chromlogD values could play a role in the loss of potency. Table 3 presents the results for the second set of compounds possessing modifications on the linker.…”

“…This assay determines the effect of the compounds on mycobacteria growing inside phagocytes/macrophages. Activity 21 in this assay is considered highly desirable as many of the bacteria during an active Mtbinfection are found intracellularly in phagocytotic cell types. The obtained results are shown in Table 5.…”

3,5-Disubstituted-indole-7-carboxamides as IKKβ Inhibitors: Optimization of Oral Activity via the C3 Substituent

“…For 27 and (R)-28 chemiluminescent nitrogen detection (CLND) was used. 18 c PAMPA values are n = 1 determinations except for 24 and (R)-28 (n = 3). Pharmacokinetic profiling was done in male Sprague−Dawley rats (n = 2) or male beagle dogs (n = 3) using 5% DMSO and 20% Cavitron for the iv leg and 5% DMSO and 6% Cavitron for the oral leg.…”

“… a Values are the mean of n ≥ 2 determinations unless noted otherwise. b Kinetic solubility was measured via HPLC using UV detection. For 27 and ( R )- 28 chemiluminescent nitrogen detection (CLND) was used c PAMPA values are n = 1 determinations except for 24 and ( R )- 28 ( n = 3). …”